Research Grade Nimotuzumab ( 尼妥组单抗 )
- 发布日期: 2020-10-28
- 更新日期: 2025-10-28
产品详请
| 产地 |
中国
|
| 品牌 |
Chemstan
|
| 货号 |
CSD00021
|
| 保存条件 |
store at -80℃
|
| 用途 |
仅用于科研用途
|
| 应用范围 |
|
| 抗原来源 |
CHO cells
|
| CAS编号 |
828933-51-3
|
| 保质期 |
一年
|
| 抗体名 |
Nimotuzumab ( 尼妥组单抗 )
|
| 是否单克隆 |
|
| 克隆性 |
|
| 靶点 |
EGFR[Homo sapiens]
|
| 适应物种 |
|
| 形态 |
|
| 宿主 |
|
| 标记物 |
|
| 包装规格 |
1mg/ml
|
| 纯度 |
%
|
| 亚型 |
|
| 标识物 |
|
| 浓度 |
95%
|
| 免疫原 |
|
| 是否进口 |
否
|
Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor (EGFR).
货号(Catalog No.)
CSD00021
通用名INN
Nimotuzumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor (EGFR).
别名(Alternative names)
Theraloc,hR3
靶点;物种(Specificity target name;species)
EGFR[Homo sapiens]
活性研究(体外/体内研究)(Activity in vitro)
Cells in the logarithmic-growth phase were cultured in 96-well plates at a density of 1×105 cells/well in triplicate. Following incubation for 24 h, nimotuzumab was added at concentrations of 2,000, 1,000, 500, 250, 125 or 62.5 μg/ml. MTT was added following incubation at 37°C for 24, 48 or 72 h, followed by the addition of 150 μl dimethyl sulfoxide into each well.
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG1-kappa
化学信息
分子量(MV)
148000.00 Da
CAS
828933-51-3
存储条件(Storage)
store at -80°C
Note
For research use only. Not suitable for clinical or therapeutic use.